Revitalising Attention on the Global Asbestos Disaster – Dr Jukka Takala, et al.
Original Article Reference
This SciPod is a summary of the paper ‘Global Asbestos Disaster’, from the International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph15051000
Share Episode
About this episode
In developed countries, we are broadly aware of the dangers of asbestos and the risks it poses if discovered in our living or working environments. It may be shocking to learn that asbestos still causes an estimated 255,000 deaths annually worldwide, with the vast majority – 89% – from work-related exposure. Although asbestos is banned in 55 countries, it is still widely used in the developing world, and over two million tonnes are consumed annually, leading to what Dr Jukka Takala, President of the International Commission of Occupational Health, and an international team of authors describe as a global asbestos disaster.
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
Related episodes
Dr. Allen Place | Small but Deadly: The Tale of K. veneficum
The oceans, huge and brimming with diverse lifeforms, pose no less a struggle for survival for their inhabitants than that faced by creatures on dry land. Evolution has furnished marine organisms with huge array of defensive, and indeed, offensive adaptations to help them to thrive in this battleground. Among the organisms who live and compete in the ocean are dinoflagellates. These are small, single-celled creatures that are an important component of plankton found in marine ecosystems. Despite their tiny size, dinoflagellates such as Karlodinium veneficum can wield potent biochemical weaponry that gives them an edge against other competing organisms. Decades since the discovery of the toxic properties of Karlodinium veneficum, researchers such as Dr. Allen Place of the University of Maryland Center for Environmental Sciences, and his colleagues, have begun to unravel the secrets of its potent toxins, called karlotoxins. Their findings offer fascinating insights into the interactions of marine life and the weapons they adopt to capture prey and deter predators.
Dr. Andrea Grindeland | The Tiny Heroes That Could Save Deer and Elk from Chronic Wasting Disease
It’s not difficult to picture a lush forest landscape populated with majestic deer and elk, long admired for their prowess and strength. Now, imagine that same scene, but instead of healthy and happy animals browsing a forest ecosystem, we see creatures that are thin and disoriented, that struggle to run or even stand, with halting and confused movements that are pitiable and distressing to watch. This is the harsh reality of Chronic Wasting Disease, an illness that currently has no cure and that threatens such wildlife around the world. Part of the challenge with Chronic Wasting Disease is the difficulty in studying it reliably in wildlife. The disease has subtle signs at an early stage, and it is difficult to obtain robust and reproducible data from large, wild animals who often live in remote and poorly accessible forest ecosystems. Consequently, researchers have turned to an unlikely but powerful ally, the tiny laboratory mouse, to model and study the disease under laboratory conditions. Dr. Andrea Grindeland of the McLaughlin Research Institute, and her colleagues, have authored a review of the existing mouse models of Chronic Wasting Disease. These tiny creatures have been engineered to mimic the biology of cervids, such as deer and elk, and are providing crucial insights into how Chronic Wasting Disease evolves, is transmitted, and how it might one day be controlled or even eradicated.
Dr Yvette Gramlich | How bursts of biomass burning can impact the Arctic
The Arctic’s climate is changing faster than almost anywhere else on Earth, but climate scientists are still uncertain how it is being affected by carbon-rich aerosols, released by fires thousands of kilometres to the south. Through their research, a team led by Dr Yvette Gramlich at Stockholm University in Sweden and the Paul Scherrer Institute in Switzerland has gained deeper insights into how these aerosols are impacting Earth’s northernmost reaches. Their work could help climate scientists to better predict how the Arctic’s climate will change in the future.
Dr. Kim Saverno | Real-World Impact: How Targeted Therapy is Changing Cholangiocarcinoma Treatment
Cholangiocarcinoma is an aggressive cancer that begins in the bile ducts. While the cancer is relatively rare, affecting approximately 8,000 people in the United States each year, unfortunately, it is often undiagnosed until an advanced stage. This late diagnosis makes cholangiocarcinoma very challenging to treat, and less than 10% of patients survive for five years after diagnosis. Traditional anti-cancer treatments, such as chemotherapy, have only limited effectiveness in cholangiocarcinoma, and can cause serious side effects. Recently developed immunotherapy and targeted therapies have provided promising options for this difficult-to-treat disease. Dr. Kim Saverno of the Incyte Corporation, a biopharmaceutical company headquartered in the U.S., and the study’s co-authors, have been studying the real-world use of an FDA-approved targeted drug for cholangiocarcinoma called pemigatinib. Pemigatinib was approved by the FDA in 2020. It can be specifically used for cholangiocarcinoma patients who have genetic changes in a protein known as fibroblast growth factor receptor 2, or FGFR2 for short. Their study, to the best of our knowledge, is the first to examine pemigatinib’s use in real-world settings, and reveals information about treatment patterns, FGFR2 testing patterns, and effectiveness of pemigatinib for cholangiocarcinoma when used in everyday practice.
Increase the impact of your research
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Step 1 Upload your science paper
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published